PriyaRastogiMD

Hematology • Pittsburgh, PA

Myeloproliferative Disorder Hematology-Oncology

Assistant Professor, Medicine, University of Pittsburgh School of Medicine

Join to view full profile

Dr. Rastogi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Rastogi's full profile

Already have an account?

Office
200 Meyran Ave
Ste 318
Pittsburgh, PA 15213
Phone+1 412-383-1650

Fax+1 412-641-1085

Education & Training

UPMC Medical EducationFellowship, Hematology and Medical Oncology, 2000 - 2003
Saint Joseph HospitalResidency, Internal Medicine, 1997 - 2000
Wright State University Boonshoft School of MedicineClass of 1997

Certifications & Licensure

PA State Medical License 2003 - 2024
American Board of Internal Medicine Medical Oncology

Clinical Trials

A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer Start of enrollment: 2010 Aug 13
Completed
Phase 3

Publications & Presentations

PubMed

2 citations
Long-term outcomes by lobular vs ductal histology in 4 National Surgical Adjuvant Breast and Bowel Project adjuvant breast cancer trials.
Julia Foldi, Neil Carleton, Stewart J Anderson, Priya Rastogi, Adrian Lee
Journal of the National Cancer Institute. 2025-01-01
Prognostic value of residual disease (RD) biology and gene expression changes during the neoadjuvant treatment in patients with HER2-positive early breast cancer (EBC).
A Fernandez-Martinez, M Tanioka, S G Ahn, P Zagami, T Pascual
Annals of Oncology. 2024-12-18
Race and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Positive Breast Cancer in the Randomized RxPONDER Trial.
Yara Abdou, William E Barlow, Julie R Gralow, Funda Meric-Bernstam, Kathy S Albain
Journal of the National Cancer Institute. 2024-12-05

Lectures

Selected Updates in Breast Cancer
2007 Annual Meeting, Chicago, Illinois, USA
Selected Updates in Breast Cancer
American Society of Clinical Oncology, 2007 Annual Meeting, Chicago, Illinois, USA

Press Mentions

Priya Rastogi on Use of the MammaPrint Assay for Predicting Benefit from Extended LetrozoleJanuary 7th, 2025
Gene Assay for MammaPrint May Predict Responses to Extended Letrozole in Low-Risk Breast Cancer SubsetsAugust 30th, 2024
Advantage of Abemaciclib plus Endocrine Therapy for Early Breast Cancer Endures at 5 YearsJanuary 23rd, 2024